Iambic Therapeutics
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- $267M
Investors
- 24
About Iambic Therapeutics
Founded in 2019 and based in California, US, Iambic Therapeutics, Inc. operates as a healthcare technology company that offers a platform that combines machine learning and automated synthetic development to design small-molecule therapeutics. In November 2025, Iambic Therapeutics, Inc.
Who invested in Iambic Therapeutics
24 investors across 5 rounds
See all investors in Iambic Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Iambic Therapeutics
Who invested in Iambic Therapeutics?
Iambic Therapeutics has 24 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Iambic Therapeutics raised?
Iambic Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Iambic Therapeutics last raise money?
Iambic Therapeutics's most recent round on record is a Series B, in Nov 2025.
What does Iambic Therapeutics do?
Founded in 2019 and based in California, US, Iambic Therapeutics, Inc.
Where is Iambic Therapeutics headquartered?
Iambic Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Iambic Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Iambic Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Iambic Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.